On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.
March 28th 2024
At week 52, investigators noted an overall improvement of 93% in PASI scores from baseline.
Tofacitinib-Treated Women With PsA Less Likely to Achieve MDA
At month 3, patients treated with tofacitinib achieved higher rates of ACR20/50, MDA, and PASI75 in both sexes when compared with the placebo. However, female patients were less likely to achieve MDA when compared with males.
Soumya Chakravarty, MD, PhD: Guselkumab Demonstrates Long-Term Efficacy in Treating PsA
Soumya Chakravarty, MD, PhD, discussed the results of the DISCOVER-1 and DISCOVER-2 studies that evaluated the long-term efficacy of guselkumab for the treatment of adult patients with active psoriatic arthritis.
Guselkumab Safety in Psoriatic Arthritis Consistent Regardless of Prior TNF Inhibitor Exposure
January 31st 2023An analysis of data from 4 phase 2/3 studies provides insight into the effects of guselkumab in psoriatic arthritis based on whether or not a person had prior exposure to TNF inhibitor therapy.
Q&A: HLA-B27 Influence on Patients with Peripheral Spondyloarthritis Phenotype
January 16th 2023In this Q&A, Mireia Moreno, MD, discussed the findings of a study that evaluated the influence of HLA-B27 in the phenotypical expression of peripheral spondyloarthritis (pSpA), including psoriatic arthritis, which is the most well-defined pSpA.
Early Achievement of Minimal Disease Activity Linked to Better Outcomes in Psoriatic Arthritis
Patients with psoriatic arthritis who achieve minimal disease activity during the first year of diagnosis are shown to experience better health-related quality of life, improved mental wellbeing, and reduced fatigue.